Jaguar Health Inc (JAGX) Stock Price & News

Why is JAGX down 11.03%?

Dive Deeper

JAGX:NASDAQ

Jaguar Health Inc

$5.00

-11.03%

(-0.62) 1D

$4.98

-0.40% (-0.020)

After hours

Closed: Oct 7, 4:00:01 PM GMT-4 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for JAGX...

Open

$5.24

High

$5.50

Low

$4.91

Mkt. cap

10.69M

Avg. vol.

4.63M

Volume

1.20M

52-wk high

$1,267.88

52-wk low

$2.37

EPS

-$6,034.53

Beta

-0.40

Shares outstanding

1.95M

No. of employees

Open

$5.24

High

$5.50

Low

$4.91

Mkt. cap

10.69M

Avg. vol.

4.63M

Volume

1.20M

52-wk high

$1,267.88

52-wk low

$2.37

EPS

-$6,034.53

Beta

-0.40

Shares outstanding

1.95M

No. of employees

Related stocks

HRTX

Heron Therapeutics Inc

$0.38

+15.86%

NCT

Intercont (Cayman) Ltd

$1.52

+1.33%

WHLR

Wheeler Real Estate Investment Trust Inc

$0.69

-24.29%

RETO

ReTo Eco-Solutions Inc

$1.57

-5.42%

News stories

From web sources and news partners

Benzinga

1 day ago

12 Health Care Stocks Moving In Tuesday's Intraday Session

Timothy Sykes

1 day ago

JAGX Stock Jumps As Rare-Disease Pipeline And Special Dividend Draw Traders

Stock Titan

1 day ago

A panel will discuss the gut lining beyond nutrition delivered through a vein on Oct. 30.

ACCESS Newswire

1 day ago

Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi

About Jaguar Health Inc

CEO-

Employees47

Founded2013

HeadquartersSan Francisco, California, United States

SectorPharmaceutical industry

Websitejaguar.health

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.08M	3.24M	20.27M	1.22M
Cost of goods sold	532.00K	2.20M	1.16M	1.03M
Cost of revenue	532.00K	2.20M	1.16M	1.03M
Research and development expenses	3.66M	14.31M	3.93M	3.34M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.13M	7.16M	5.00M	4.46M
Operating expense	9.79M	21.48M	8.93M	7.79M
Total operating expenses	10.32M	23.68M	10.09M	8.82M
Operating income	-7.24M	-20.44M	10.18M	-7.60M
Other non operating income	-2.40M	-1.84M	-132.00K	-1.54M
EBT including unusual items	-9.65M	-23.19M	8.72M	-12.80M
EBT excluding unusual items	-9.65M	-22.42M	9.35M	-9.30M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-9.50M	-23.06M	8.85M	-12.68M
Net profit margin	-308.21%	-712.86%	43.65%	-1,035.27%
Earnings per share	-3.30K	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-6.00K	-132.00K	-699.00K	-161.00K
Net interest expenses	-6.00K	-132.00K	-699.00K	-161.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-6.76M	-19.96M	10.66M	-7.12M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything